The tgt is very light IMO and should advance well beyond that. All the insiders have been buying very big blocks. That is "always" a ver, very encourging sign. The spinning shorts ofcourse have their comments and side that will always be negitive. Why, because they are short and will spin it and slant it all day and every day. We all know this, nothing new. Over shorted to begin with.
with 44% short they are not going away anytime soon and or with out a fight to the death. They will use every blogger, analyst and other sites as well as the bashers big time. Think about it. 120 mil + short. Every dollar it goes up it cost them over 100 million dollars. This goes back to the highs of over 11.00 That is a billion dollars. No they are not going away anytime soon. They will continue down this path of deception, manipulation, lies and fear mongering to the end. The system is all in their favor. They have the cash to pay anyone and everyone to do their bidding for real.
Yes this is jus short BS as usual for sure. They will have more cash to put to good use and save millions. The revenue streem hasn't changed at all. No one was buing into the femprox issue in the first place as being successful as many have mentioned many many times. No one was buying the "potential" in the first place they were buying the revenues. Just smoke and mirrors from the shorts over this non-issue in totallity. This is not a bad thing it is a good thing not to continue down a dad end road spending good money after bad. I believe we all know that.
Yes and when that good news comes out the shorts will gwt squeezed big time. Ofcourse you are going to get 24/7 bashing by shorts why wouldn't they. They are short. Undevalued here at thie pps. There are tons of companies that have far, far less that are trading 5/8 times more.I believe we all know that. The shorts do not want any buyers fo sure.
going to be a very good Q on the 9th. They want you out before the 9th. PPS is going to tripple and a squeeze will be at hand.
I still can't get over all this in fighting over a penny here and there for real. Makes no sence to me. Let it go and everyone is happy, everyone makes money. Does the shorts, traders or whomever really have to have all the shares they can manipulate out of investors. Is the greed really that bad. I guess so. The shares bought by the insiders can not be sold until 20 for four straight days. When they need those shares to over they will have to let it go then. The next positive pr will do it. Could be at any time. I believe that this new team will get the ball rolling very, very soon. Have a very good feeling about a partner as well.
It is hard to believe only four senators opposed the confirmation of Robert Califf, who was approved Wednesday as the next Food and Drug Administration (FDA) commissioner. Vocal opponent Bernie Sanders condemned the vote from the campaign trail. But where was #$%$ Durbin? Where were all the lawmakers who say they care about industry and Wall Street profiteers making money at the expense of public health? Califf, chancellor of clinical and translational research at Duke University until recently, received money from 23 drug companies including the giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK according to a disclosure statement on the website of Duke Clinical Research Institute. ..
There was a new head of the fda apointed today a rep who is said to be believed in high favor of the large pharmas. This is not good for the mkt as a whole if true as he will block and or make it difficult for other necessary and good drugs to hit the mkt. We are already well, well back behind the EU in this matter. I'll have to dig a little more to find out about this guy - new fda director.
They are manipulating before partner announcement. They don't want the cos employees to get paid on their 20% investment which has to trade above 20 for four consecutive days either. There is a short vendata agains the co. I believe it is an old score someone wants to settle
There was NO moneys coming in from this trail, only money going out and none of that had any influences on the analysts who solely looked at the revenues. Now eliminate all the cost with these trails and put that money into the co. Not going to fight with all the short sellers over this issue. Of course it owuld have been great to move along, but that wasn't the only deal here. Now that has been cleaned up the co can move ahead. This time with a lot more cash on hand.
Further more the elimination of the burn go a long way to enhance more profit. Not that difficult to figure out here people. The spinners will spin the spin but this is positive news not negitive news. They also will be eliminating jobs conected with those trials as well. More cash in the pockets of the co. The bottom line for the co will be increasing from here Q to Q.
The analysts are positve because of earnings no the drugs potential KEEP THAT IN MIND.
One stock that might be an intriguing choice for investors right now is Peregrine Pharmaceuticals, Inc.
. This is because this security in the Medical-Biomedical/Generic space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical-Biomedical/Generic space as it currently has a Zacks Industry Rank of 67 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.
Meanwhile, Peregrine Pharma is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm's prospects in both the short and long term.
In fact, over the past two months, current quarter estimates have narrowed from a loss of 9 cents per share to a loss of 7 cents per share, while current year estimates have narrowed from a loss of 34 cents per share to a loss of 29 cents per share. This has helped PPHM to earn a Zacks Rank #1 (Strong Buy), further underscoring the company's solid position.
So, if you are looking for a decent pick in a strong industry, consider Peregrine Pharma. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.
I see it as putting more money in the cos coffers and not spending any more cas and eliminating the burn rate. They still still have a very good cash flow. It is not that bad as some may put it out there quit the opposite.
be patient. shorts are doing a little shake out is all. Volume is about 1 mil. They are loading up. watch and learn. Nothing to get excited about. It's all good.
I don't know what chart you are looking at but the one I am looking at says a very, very different thing. All pointing north. 99% of all indicators are showing north.
I believe that they have set a range between 18 to 20 and that is where the play is for now. Positive news will change that. One of the biggest key real factors is that the insiders can not sell untill this trades above 20 for rour consecutive days. They can take it over 20 and drop it down and keep it so that there is no consecutive days for the insiders. That's all great and for sure the deal, but that isn't it for this co setteling for a mere 20 cents either. With 82 new cases of zika and the need to find a cure, the restart up of the plant and the partner in the works this has a much higher and stronger potential than a mere 20 cents for sure.